The TUDCA-ALS Open label extension study is designed to investigate long term safety, tolerability and efficacy of tauroursodeoxycholic acid in patients with ALS who completed the TUDCA-ALS study
This study will provide extended access to patients and assess longer-term outcomes on patients who have completed the TUDCA-ALS study.